Consequently, molecules that play a key role in promoting angiogenesis, such as vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), and the angiopoietin/Tie2 receptor complex, are considered good targets for anti-tumor therapies [12]. The gene discussed is VEGFA; the disease is neoplasm.